about
Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study.Selecting the right indicators to ensure optimised implementation of BCG vaccination policy.Non-live pentavalent vaccines after live measles vaccine may increase mortalityIs early measles vaccination associated with stronger survival benefits than later measles vaccination?Implementation and assessment of vaccination programmes: the importance of vaccination sequence for overall health outcomes"Every Newborn-INDEPTH" (EN-INDEPTH) study protocol for a randomised comparison of household survey modules for measuring stillbirths and neonatal deaths in five Health and Demographic Surveillance sitesComment on the trial protocol "Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial"The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-BissauNeonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort studyReducing missed opportunities for vaccinations should be done with eyes wide openCan earlier BCG vaccination reduce early infant mortality? Study protocol for a cluster randomised trial in Guinea-BissauRandomised comparison of two household survey modules for measuring stillbirths and neonatal deaths in five countries: the Every Newborn-INDEPTH studyResearch protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among childrenHousehold costs of seeking BCG vaccination in rural Guinea-BissauCohort profile : Bandim Health Project's (BHP) rural Health and Demographic Surveillance System (HDSS)-a nationally representative HDSS in Guinea-BissauOut-of-sequence DTP and measles vaccinations and child mortality in Guinea-Bissau: a reanalysis
P50
Q33868334-D2700C90-2B93-45C6-9283-3A49B5C23F59Q39150926-4C92968E-BEA6-4896-A294-1CB96C86EB44Q48323075-1CA737FF-DACF-4506-B643-F1A7C9EC816EQ53683480-AE465C07-54C1-4563-8ED7-5411BBD9E892Q56839511-6A925EC6-BA0C-4F62-9824-D503DDEFCCBEQ56839512-A31995C1-99CF-4A17-87DE-0B63CB6216EEQ56839513-4481CE7E-67F4-440F-9F64-69BD6AF2A5A6Q64114683-5B09ED6C-3A76-4676-B580-56CDA360DF25Q64239851-733CCADF-95E4-4E25-A50A-C4C35807ED44Q89727561-0A76E8F4-87F7-4D0B-8914-E93A459E853DQ89957426-B002ECE2-8060-4F45-8D48-171BA32150F8Q90222272-67C80416-1038-41EF-960E-E6503463AF58Q90261262-BF6A6FD3-DB5C-466F-A8B7-C4BAA9B346FEQ90559495-A2E8036C-695C-4E64-A8E3-5B18C1A08D8CQ91229475-BA1B89D3-2041-4304-98B8-0B926511CEA5Q92574350-A38880BA-57AE-4BD9-A791-515E881BEE68Q92689576-3B0D08AD-382C-444E-856C-E440360A7E9DQ93161422-739A10F8-1E86-436C-BEF3-A0CACFEB86F2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sanne Marie Thysen
@ast
Sanne Marie Thysen
@en
Sanne Marie Thysen
@es
Sanne Marie Thysen
@nl
type
label
Sanne Marie Thysen
@ast
Sanne Marie Thysen
@en
Sanne Marie Thysen
@es
Sanne Marie Thysen
@nl
prefLabel
Sanne Marie Thysen
@ast
Sanne Marie Thysen
@en
Sanne Marie Thysen
@es
Sanne Marie Thysen
@nl
P106
P31
P496
0000-0003-4541-3901